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ABSTRACT 
Mitochondria are known to actively regulate cell death with the final phenotype of 
demise being determined by the metabolic and energetic status of the cell. 
Mitochondrial membrane permeabilization (MMP) is a critical event in cell death, as it 
regulates the degree of mitochondrial dysfunction and the release of intermembrane 
proteins that function in the activation and assembly of caspases. In addition to the 
crucial role of proapoptotic members of the Bcl-2 family, the lipid composition of the 
mitochondrial membranes is increasingly recognized to modulate MMP and hence cell 
death. The unphysiological accumulation of cholesterol in mitochondrial membranes 
regulates their physical properties, faciliating or impairing MMP during Bax and death 
ligand-induced cell death depending on the level of mitochondrial GSH (mGSH), which 
in turn regulates the oxidation status of cardiolipin. Cholesterol-mediated mGSH 
depletion stimulates TNF-induced reactive oxygen species and subsequent cardiolipin 
peroxidation, which destabilizes the lipid bilayer and potentiates Bax-induced 
membrane permeabilization. These data suggest that the balance of mitochondrial 
cholesterol to peroxidized cardiolipin regulates mitochondrial membrane properties and 
permeabilization, emerging as a rheostat in cell death. 
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1. INTRODUCTION 
 
Mitochondria play a central role in various forms of cell death which are characterized 
by differential biochemical features that include apoptosis (caspase-dependent and 
independent), necrosis and autophagy. A key event in this role is the breakage of 
mitochondrial membranes, particularly the outer mitochondrial membrane, which 
allows the release of proapoptotic factors that engage the apoptosome resulting in 
apoptotic cell death. Understanding the mechanisms leading to mitochondrial 
membrane permeabilization (MMP) is thus central to the design of estrategies to control 
cell death. In pathologies associated with enhanced cell death such as liver diseases (e.g. 
steatohepatitis) or neurodegeneration (e.g. Alzheimer´s disease), the therapeutic goal is 
to prevent or ameliorate the extent of cell death. In contrast, in cancer the primary 
interest is to kill tumor cells more efficiently sensitizing them to current cancer therapy. 
Although a major focus in the field has been paid on the role of Bcl-2 family members 
in the regulation of MMP and cell death [1, 2], an increasing body of evidence points to 
a key role of lipids in the regulation of MMP and cell death susceptibility. In particular, 
mitochondrial cholesterol has emerged as an important modulator of MMP in response 
to apoptotic stimuli including hypoxia, TNF, amyloid beta peptide (A ) or Bax, 
underlying the importance of this particular bilayer component in disease pathogenesis, 
including alcoholic and nonalcoholic steatohepatitis, Alzheimer´s disease or 
hepatocellular carcinoma [3, 4]. Although the unphysiological accumulation of 
cholesterol shields mitochondrial membranes impairing the bilayer permeabilization, as 
shown in model membranes, this effect can be counterbalanced by the presence of 
peroxidized cardiolipin, which is in turn regulated by the availability of mitochondrial 
GSH (mGSH) [3]. Thus, mitochondrial cholesterol plays a paradoxical role in cell death 
depending on the regulation of mitochondrial GSH (mGSH) transport, mGSH 
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homeostasis and subsequent protection of cardiolipin from peroxidation. In this review, 
we will briefly summarize the implications of the enrichment of mitochondrial 
membranes in cholesterol and its impact in mitochondrial membrane properties, mGSH 
regulation, cardiolipin status, and cell death. 
2. MITOCHONDRIAL PATHWAY OF CELL DEATH 
Apoptosis is a specific form of cell death which is essential for life as it is required for 
embryonic development, tissue homeostasis and immune defense. Dysregulation of 
apoptosis, however, contributes to many pathophysiological states and diseases. The key 
mediators of apoptotic cell death are cysteine proteases, called caspases, that work in a 
coordinated cascade to cleave key substrates that dismantle the cell with characteristic 
biochemical features [5, 6]. Apoptosis can occur through two main pathways, the 
extrinsic pathway and the intrinsic pathway. The former is initiated upon the binding of 
an extracellular ligand to transmembrane death receptors of the TNF supefamily, which 
leads to the assembly of the death-inducing signalling complex (DISC) [7, 8]. The DISC 
then activates an initiator caspase, which triggers the enzymatic cascade that leads to 
apoptotic death. The intrinsic pathway is also known as the mitochondrial pathway and is 
activated by stimuli that lead to the permeabilization of mitochondrial outer membrane 
(MOM) and the subsequent release of proteins, such as cytochrome c, from the 
mitochondrial intermembrane space (IMS), which initiate and regulate caspase activation. 
Cytochrome c normally resides within the cristae of the mitochondrial inner membrane 
(MIM) and is effectively sequestered by narrow cristae junctions. Within the MIM, 
cytochrome c participates in the mitochrondrial electron-transport chain, using its haem 
group as a redox intermediate to shuttle electrons between complex III and complex IV. 
However, in response to specific apoptotic triggers, such as DNA damage, or metabolic 
stress, the intrinsic apoptotic pathway is activated and mitochondrial cytochrome c is 
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released into the cytosol [2]. This process is thougth to occur in two phases, first the 
mobilization of cytochrome c and then its translocation through permeabilized MOM, 
described below. In addition to cytochrome c, other IMS proteins are mobilized and 
released into the cytosol. For instance, the release of Smac/Diablo into the cytosol 
ensures the efficiency of caspase 3 activation in degrading target proteins through 
inhibition of inhibitor of apoptosis proteins (IAPs) [9, 10]. Furthermore, the 
mitochondrial protein Omi/HtrA2 promotes cell death in a dual fashion. Besides its IAP 
activity Omi/HtrA2 also functions as a serine protease, contributing to both caspase-
dependent and caspase-independent cell death [11, 12]. Moreover, other specialized 
mitochondria-resident proteins, such as the apoptosis inducing factor (AIF) [13] and 
endonuclease G [14], are translocated to the nuclei following their release from 
mitochondria and promote peripheral chromatin condensation and high molecular weight 
DNA fragmentation. An important feature of apoptosis is its dependence on energy by 
sustained ATP supply to support caspase activation [2, 5, 6]. 
In contrast to apoptotic cell death, necrotic cell death is characterized primarily by the 
rapid loss of cellular membrane potential, which leads to cytoplasmic swelling, rupture 
of the plasma membrane, and cytolysis. The extent of mitochondrial dysfunction and 
the rupture of MIM impairs the ability of mitochondria to generate ATP, needed for the 
function of homeostatic ion pumps/channels, and the generation of reactive oxygen and 
nitrogen species (ROS/RNS), which in turn, can regulate caspase activation [15]. The 
onset of necrotic cell death can also occur in the extrinsic pathway by death receptors, 
such as TNF or Fas. FADD, a DISC  component, has been shown to be involved in 
TNF-induced necrosis [16, 17]. RIP1 also contributes to death receptor-induced 
necrosis, as RIP1-deficient T cells are also resistant to death induced by TNF and Fas in 
the presence of caspase inhibitors [17]. The kinase activity of RIP appears to be 
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required for necrosis induction, although its targets remain to be identified. Necrostatin-
1, a small molecule that can inhibit necrosis induced by RIP or by TNF and Fas in the 
presence of caspase inhibitor [18], may be a valuable tool to disclose signaling 
pathways involved in death receptor-mediated necrosis. Thus, while mitochondria play 
a key role in the control of cell death, the phenotype of the dying cell depends on the 
metabolic and energetic status of the cell that determine the level and extent of caspase 
activation. 
 3.MITOCHONDRIAL MEMBRANE PERMEABILIZATION AND 
CYTOCHROME C RELEASE 
The mechanisms of MMP and cytochrome c release from IMS have been an intense 
area of research, whose understanding may be important to control cell death. Indeed, 
this is a critical issue because, in addition to cytochrome c, other proteins are also 
released from the intermembrane space into the cytosol, where they engage in a 
strategic battle to promote or counteract caspase activation and hence cell death, as 
described above. The intricacy of this pathway highlights the central role of 
mitochondria in regulating cell death, regardless of the phenotype of death (caspase-
dependent apoptosis, caspase-independent apoptosis, or necrosis). Since these 
proapoptotic proteins are normally confined in the IMS, the events that culminate in the 
rupture of the physical barrier (MOM), which limits their release into the cytosol, 
constitute a point-of-no-return in cell death [2]. While the underlying mechanisms are 
not completely understood, there has been evidence for two possible mechanisms 
leading to the breakage of MOM: the mitochondrial permeability transition (MPT), and 
the permeabilization of MOM without disruption of the inner membrane, which is 
regulated by Bcl-2 family. The usually impermeable MIM prevents unrestrained influx 
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of low-molecular-weight solutes into the mitochondria. The MPT features 
mitochondrial swelling, uncoupling and MIM permeabilization to small solutes, which 
results in a colloidal osmotic pressure that leads primarily to massive swelling of the 
mitochondrial matrix sensitive to cyclosporine A [2, 19, 20]. As a consequence of MPT 
the MOM ruptures and cytochrome c and other IMS proteins are released into the 
cytosol. MTP is most likely assembled at the contact sites of the MOM and the MIM 
and the actual components of the MTP remain ill defined. Although MPT has a 
definitive role in regulating MMP, mitochondrial dysfunction and cell death, this 
mechanism seems to play a minor role in apoptotic cell death as opposed to necrosis. 
For instance, deficiency of VDAC isoforms or cyclophilin D, two essential MPT 
components, does not prevent apoptosis induced by Bcl-2 family members, but impairs 
Ca
2+
-mediated MPT and ischemia-reperfusion necrosis [21-23]. Alternatively to MPT, 
Bcl-2 family members control MOM permeabilization. Bcl2-family death agonists 
induce OMM permeabilization, thereby promoting cytochrome c release, whereas Bcl2-
family death antagonists prevent it. Thus, Bcl2-family proteins control mitochondrial 
integrity, regulate cytochrome c release and intrinsic apoptosis [1]. Under non-apoptotic 
conditions, Bax is inactive and present in the cytosol as a monomer. Following an 
apoptotic stimulus, Bax is activated and translocates to the mitochondria, where it 
undergoes a conformational change and inserts into the MOM. Bax oligomerization is 
associated with the formation of openings in the MOM to allow the release of 
cytochrome c and other IMS proteins into the cytosol, and hence Bax oligomerization is 
considered a critical regulatory point in cell death [1, 2]. In contrast to Bax, Bak resides 
on the MOM rather than in the cytosol but, like Bax, it undergoes a conformational 
change in response to apoptotic stimuli. This change allows Bak to oligomerize, 
contributing to MOM permeabilization. One potential mechanism involved in the 
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permeabilizing activities of Bax/Bak oligomers is the formation of pores in MOM. 
However, attempts to visualize these oligomers have shown that large clusters of Bax 
are localized near, but not on, the MOM [1]. An alternative model suggests that the 
insertion of activated, oligomerized Bax and/or Bak into the MOM creates a positive 
curvature stress on the membrane, leading to supramolecular pores that include lipids in 
the MOM [24-26]. Clearly, understanding the mechanisms underlying MOM 
permeabilization may provide novel strategies to regulate cytochrome c and hence 
apoptosis. The relative prevalence of these pathways in the regulation of cell death is 
not definitively established. One important feature of mitochondrial membrane 
permeabilization is the loss of function resulting in the inability of mitochondria to 
synthesize ATP through the oxidative phosphorylation. However, while the final 
outcome of mitochondrial dysfunction is cell death, as mentioned above, the phenotype 
of death, apoptosis and/or necrosis, is dependent on the level of cellular ATP as ATP is 
required for the efficient assembly of the apoptosome and/or the extent of ROS 
generation [1, 2]. 
In addition to understanding the mechanisms leading to MOM permeabilization to 
design strategies to control cell death, another level of control centers on the 
mechanisms underlying the mobilization of cytochrome c from IMS. It has been 
proposed that during mobilization cytochrome c detaches from the MIM and dissociates 
from the membrane phospholipid cardiolipin [27]. A significant proportion of the 
cytochrome c in the mitochondria seems to be associated with cardiolipin, involving 
two major mechanisms. At physiological pH, cytochrome c has 8 positive net charges, 
establishing an electrostatic bond with the anionic cardiolipin. In addition, cytochrome c 
has a hydrophobic channel through which one acyl chain of cardiolipin inserts. The 
other chains of cardiolipin remain in the membrane, thereby anchoring cytochrome c to 
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the MIM [28]. One mechanism involved in cytochrome c detachment from MIM 
involves cardiolipin oxidation because oxidized cardiolipin has a lower affinity for 
cytochrome c than the unoxidized form [29, 30]. Cardiolipin can be oxidized by ROS, 
which are controlled by mitochondrial antioxidants such as GSH [30, 31] or by the 
cardiolipin–cytochrome c complex [32]. Detachment of cytochrome c from cardiolipin 
might also be triggered by increased cytosolic Ca
2+
, which weakens the electrostatic 
interaction between cytochrome c and cardiolipin. In addition, as described below, 
oxidized cardiolipin modulates the biophysical properties of MOM to allow 
oligomerized Bax to insert and permeabilized MOM [30]. 
In contrast to this view, other evidence neglects the mobilization of cytochrome c from 
MIM as a requirement for its release into the cytosol. In isolated mitochondria, exposure 
to 50–80 mM K+, a concentration of intracellular K+ that is within physiological limits, 
causes the release cytochrome c from the IMM [33]. In addition, live-cell imaging has 
revealed no differences in the kinetics of the release of cytochrome c compared with 
other IMS proteins in cells undergoing apoptosis [34]. These results imply that 
cytochrome c mobilization might not require an additional step in its release from the 
mitochondria. In addition, mobilization of cytochrome c might also involve its removal 
from narrow cristae junctions, although this specific issue is controversial. For instance, 
it has been suggested that the remodelling of cristae is required in the release of this 
interior pool of cytochrome c [35], and recent studies correlated the disassembly of 
Opa1 oligomers, a structural determinant of cristae morphology, with the remodelling of 
cristae [36]. However, using three-dimensional electron microscope tomograpy, it has 
been shown that cristae remodelling is not required for efficient release of cytochrome c 
[37]. Moreover, BH3-only proteins Bid and Bim induced full cytochrome c release but 
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only a subtle alteration in cristae junctions, which involved the disassembly of Opa1 
complexes [38].  
4. CHOLESTEROL IN MITOCHONDRIAL MEMBRANE PROPERTIES, MMP 
AND CELL DEATH 
Cholesterol is a critical component of membranes with key structural and functional 
roles [39]. Compared to plasma membrane mitochondria are cholesterol-poor organelles 
with estimates of about 3-5% of the total cholesterol cell load. However, this restricted 
pool of cholesterol in mitochondria plays a fundamental physiological role such as in 
the synthesis of bile acids in hepatocytes or steroidogenic hormones in specialized 
tissues [3]. Given the role of cholesterol in the regulation of membrane dynamics and 
physical properties, the synthesis and supply of membrane cholesterol is highly 
regulated under physiological conditions. Cholesterol is synthesized in the ER and 
delivered to other organelles, including mitochondria, by a combination of vesicular and 
non-vesicular transport processes [39, 40]. Since cholesterol is very insoluble in water, 
it must be shuttled by carriers. The mechanisms of non-vesicular cholesterol transport 
are poorly understood, although there is increasing evidence that this is the major route 
for cholesterol movement between organelles. In the case of cholesterol trafficking to 
mitochondria, the best characterized example of non-vesicular mechanism involves the 
steroidogenic acute regulatory protein (StAR), which is the prototype for the StAR-
related lipid transfer (START) family of transport proteins. StAR plays an essential role 
in the delivery of cholesterol to mitochondria, where it is used in steroid hormone 
synthesis in steroidogenic tissues or in the acidic pathway of bile acid synthesis in 
hepatocytes [39, 41]. Cholesterol is known to regulate membrane physical properties 
and membrane organization. In particular cholesterol regulates the coexistence within 
membranes of lipid-disordered and lipid-ordered phases, which regulates their 
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permeability and function of resident proteins. In this regard, it has been shown that 
cholesterol loading in mitochondria results in increased membrane order parameter 
which impacts negatively in specific membrane carriers, such as the GSH transport 
system without effect in others, including the S-adenosyl-L-methionine transport system 
[42]. Since GSH is synthesized de novo exclusively in the cytosol but not in 
mitochondria, the mitochondrial source of GSH depends on its transport from cytosol 
by the 2-oxoglutarate and dicarboxylates carriers, which have been previously 
characterized [43, 44]. Functional expression studies in Xenopus laevis oocytes 
provided clear evidence that the 2-oxoglutarate carrier is highly sensitive to 
mitochondrial membrane fluidity loss induced by cholesterol loading [44]. Coupled 
with previous findings showing low and high affinity components for the mitochondrial 
transport of GSH into rat liver mitochondria, the 2-oxoglutarate carrier accounts for the 
low affinity transport site with the dicarboxylate playing a minor role. Thus, one of the 
functional consequences of mitochondrial cholesterol enrichment is the impairment of 
mitochondrial GSH (mGSH) transport which results in its depletion in the 
mitochondrial matrix, promoting the stimulation of mitochondrial ROS induced by 
death ligands (e.g. TNF) (Figure 1). This paradigm would favor the peroxidation of 
cardiolipin by enhanced ROS, which destabilizes the lipid bilayer potentiating MOM 
and subsequent release of cytochrome  c. Since GD3 is a key component of raft like 
domains and shown to promote MOM [15], it is conceivable that the enhanced 
mitochondrial cholesterol loading may result also in the enrichment of GD3 in specific 
domains of mitochondrial membranes possibly associated with peroxidized cardiolipin, 
although this remains to be established. 
4.1 Mitochondrial cholesterol in liver diseases and neurodegeneration 
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One of the most common forms of liver disease worldwide is steatohepatitis, which 
encompasses both alcoholic (ASH) and nonalcoholic steatohepatitis (NASH). While the 
pathogenesis of these diseases are obviously different, they exhibit indistinguisable 
histological features and commom underlying mechanisms of disease progression that 
start with hepatic steatosis. Although fat infiltration in these diseases is heterogenous 
consisting primarily of triglyceride, free fatty acids and cholesterol, recent studies have 
pointed to an emerging role for cholesterol, particularly in mitochondria, in the 
progression from steatosis to steatohepatitis as it sensitizes hepatocytes to inflammatory 
cytokines (e.g. TNF/Fas ligand) [45]. Moreover, massive triglyceride accumulation in 
the liver of transgenic mice overexpressing DGAT2 did not impair insulin sensitivity, a 
hallmark feature of NASH [46]. In addition, unchanged hepatic free fatty acids levels 
were reported in patients with NASH compared to healthy controls, while the degree of 
free cholesterol accumulation correlated with disease progression [47, 48]. The 
underlying mechanism for the sensitization of mitochondrial cholesterol-loaded 
hepatocytes to TNF/Fas and hence steatohepatitis involved the selective mGSH 
depletion, an outcome also observed in models of ASH [43, 45]. Two pieces of 
evidence supported this contention. First, the replenishment of mGSH by permeable 
precursors, such as GSH ethyl ester, protected mitochondrial cholesterol-loaded 
hepatocytes induced by alcohol feeding or genetic models against TNF/Fas-mediated 
cell death. Second, control hepatocytes selectively depleted of mGSH reproduced the 
sensitization to TNF/Fas observed in the nutritional and genetic models of hepatic 
steatosis characterized by cholesterol accumulation. In this paradigm, we have observed 
that mGSH depletion sensitizes to TNF/Fas by enhancing the mitochondrial generation 
of ROS via acidic sphingomyelinase-induced ceramide generation, without inactivation 
of NF- B-dependent survival pathway [30]. Moreover, mGSH depletion potentiated 
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TNF-induced cardiolipin peroxidation, which facilitated the permeabilizing activity of 
oligomerized BAX in the OMM (see below). 
Neurodegeneration reflects a number of hereditary or sporadic diseases characterized by 
progressive atrophy and neuronal loss, which include major diseases such as Alzheimer’s 
disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). AD is 
characterized by progressive memory loss and cognitive impairment whose incidence is 
associated with aging. Despite intense research, the molecular pathogenesis of AD is still 
incompletely unknown. One of the main features of AD involves the deposition in the 
brain of senile plaques, consisting predominantly of the A  peptide of 40-42 amino acid, 
which is thought to play a key role in AD [4]. Indeed, using longitudinal in vivo 
multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) 
transgenic mice, it was observed that A  plaques formed very quickly, within 24 h. 
Following plaque's appearance, microglia become activated and recruited to the site. 
Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the 
next days to weeks, thus critically establishing that A  plaque formation precedes disease 
progression [49]. In addition to aging, epidemiological observations identified 
hipercolesterolemia as a major risk factor for sporadic AD [4, 50, 51]. In this regard, the 
role of statins in AD, however, has been controversial, although the epidemiological 
evidence linking cholesterol to AD has been supported by in vivo and in vitro data. Indeed, 
since the amiloidogenic processing of the amyloid precursor protein by the presenilin1/ -
secretase is thought to occur in specific microdomains of the plasma membrane, 
cholesterol enrichment favors the generation of A  peptide and hence neurite degeneration 
[52]. Consistent with the mitochondrial targeting of A  as a major mechanism involved in 
A -induced neurotoxicity, the specific role of mitochondrial cholesterol in this context has 
been recently evaluated. Using genetic mouse models of cholesterol accumulation, it was 
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observed mitochondrial cholesterol enrichment in transgenic SREBP-2 and NPC1 
knockout mice which determined enhanced susceptibility to A -mediated 
neuroinflammation and neurotoxicity due to mGSH depletion [53]. Moreover,  APP/PS1 
transgenic mice exhibited enhanced mitochondrial cholesterol loading and subsequent 
mGSH depletion. Isolated mitochondria from these mice exhibited increased susceptibility 
to A -mediated cytochrome c and Smac/Diablo release, indicative of MMP, and caspase 
activation than wild type mice. Of relevance, the onset of AD symptons in vivo were 
prevented by mGSH recovery with GSH ethyl ester, thus pointing that strategies aimed to 
boost this particular pool of GSH may be of potential relevance in AD. 
4.2 Mitochondrial cholesterol and cancer therapy 
Cancer cells exhibit critical metabolic transformations regarding the cholesterol 
homeostasis best illustrated by the ability of solid tumors to synthesize cholesterol under 
hypoxia, which contrasts with the physiological requirement for oxygen in the 
transformation of lanosterol into cholesterol involving 9 redox reactions [3, 39]. Moreover, 
recent observations indicated that hypoxia stimulates the degradation of HMG-CoA 
reductase, ther rate-limiting enzyme in cholesterol synthesis [54]. In addition to this 
continued cholesterol synthesis in growing tumor cells, we have recently observed the 
stimulation of cholesterol trafficking to mitochondria from hepatocellular carcinoma 
(HCC) cells due to the overexpression of StAR [55]. Previous studies have shown that 
cholesterol enrichment of rat liver mitochondria impairs the ability of atractyloside to 
induce MPT [56], which suggest that mitochondrial cholesterol loading may actually 
account for the recognized mitochondrial dysfunction occurring in cancer cells (Figure 2). 
In addition to this putative effect of cholesterol in the regulation of mitochondrial function 
of cancer cells, we focused on the role of mitochondrial cholesterol in chemotherapy 
sensitivity and cell death regulation. Indeed, HCC mitochondria exhibit increased 
 15 
membrane order and resistance to Bax-mediated MMP, which are reversed either by 
cholesterol extraction with methylcyclodextrin or membrane fluidification by A2C [55]. 
Observations in HeLa cells treated with U18666A, which results in mitochondrial 
cholesterol loading, indicated a delayed release of Smac/Diablo and cytochrome c, as well 
as in BAX oligomerization and partial protection against stress-induced apoptosis [57]. 
Consistent with our findings in HCC, data from liposomes entrapping fluorescent dextrans 
indicated that the presence of cholesterol in the bilayer impaired Bax-mediated 
permeabilization due to the combination of reduced membrane dynamics and decreased 
Bax integration into the bilayer [55]. Moreover, the silencing  of StAR downregulated 
mitochondrial cholesterol levels and sensitized HCC cells to chemotherapy, similar to the 
findings observed with statins or squalene synthase inhibition,  which resulted in 
downregulation of cholesterol loading [55]. Thus these findings clearly identify the 
mitochondrial cholesterol pool as a novel mechanism whereby cancer cells, particularly 
HCC resist chemotherapy and evade Bax-mediated MMP and subsequent apoptosis.  
5. ROLE OF CARDIOLIPIN/PEROXIDIZED CARDIOLIPIN IN CELL DEATH 
Cardiolipin is a mitochondria-specific phospholipid, which plays an essential role in the 
organization of mitochondrial electron transport complexes involved in the generation 
of energy [27]. Accumulating evidence suggests that this unique lipid also has an active 
role in several of the mitochondria-dependent steps of apoptosis, namely, in the 
regulation of MOM, mobilization of cytochrome, and more recently, in the anchoring of 
caspase-8 to mitochondria during death receptor-induced apoptosis [58]. Mature 
cardiolipin is synthesized by the sequential participation of phospholipase A, which 
removes one saturated acyl chain to generate monolysocardiolipin, and by tafazzin, a 
mitochondrial enzyme that catalyzes the addition of an unsaturated chain to 
monolysocardiolipin [59]. It provides a docking site for the interaction and activation of 
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proapoptotic Bcl-2 proteins (tBid) in intact mitochondria [60], while studies in 
liposomes and outer mitochondrial membrane vesicles demonstrated the requirement for 
intact cardiolipin in the bilayer for efficient poration by active Bax [26]. Thus, these 
data indicate that cardiolipin cooperates with Bax to form large-scale openings 
independently of the formation of large (>100kDa) Bax aggregates. Besides the role of 
cardiolipin in Bax-mediated MOM permeabilization, cardiolipin has an important 
function in the attachment of cytochrome c to MIM and in the modulation of its release 
from IMS. An additional role involves the generation of a peroxidase complex brought 
about between cytochrome c-cardiolipin interaction which contributes to the oxidation 
of cardiolipin into peroxidized cardiolipin [32]. Although the generation of peroxidized 
cardiolipin from intact cardiolipin contributes to the detachment of cytochrome c from 
the inner membrane, the exact mechanism whereby peroxidized cardiolipin facilitated 
MOM permeabilization and cytochrome c release was unclear. In this regard, we 
examined this critical issue using primary hepatocytes which have been selectively 
depelted of mGSH. First, we observed that mGSH controls the formation of cardiolipin 
peroxidation during TNF-mediated hepatocellular cell death by regulating ROS 
generation [30] (Figure 1). Hepatocytes selectively depleted of mGSH 
pharmacologically potentiated cardiolipin peroxidation induced by TNF by a 
mechanism dependent on acidic sphingomyelinase (ASMase), as ASMase defiency 
impaired TNF-induced peroxidized cardiolipin despite mGSH depletion. Intriguingly, 
this outocome was observed despite the maintenance of glutathione peroxidase and 
thioredoxin-III functional activities, indicating the critical role of mGSH in the 
scavenging of mitochondrial peroxides generation. In addition, using liposomes 
mimicking the composition of mitochondrial outer membrane entrapping fluorescent 
dextrans, we observed that the incorporation of peroxidized cardiolipin in the bilayer 
 17 
enhanced the pore forming activity of active Bax by restructuring the lipid bilayer 
through a mechanism promoting the lamellar-to-inverted hexagonal lipid phase 
transition [30]. Thus, peroxidized cardiolipin seems to play a dual in mitochondrial 
apoptosis, facilitating the mobilization of cytochrome c from the inner membrane 
available for release while promoting the ability of Bax to permeabilize MOM. 
Another novel function of cardiolipin in cell death, has been the recently described 
effect in regulating the activation of apycal caspase-8 in type II cells [58]. Following an 
external stimuli, caspase-8 translocated to mitochondria to bind to sites enriched in 
cardiolipin resulting in its proteolytic activation. Interestingly, recent evidence indicated 
that these activating platforms enriched in cardiolipin corresponds to sites also enriched 
in ganglioside GD3 and cholesterol, suggesting the presence of raft-like domains, which 
have been described in cells undergoing apoptosis [61, 62]. Therefore, cardiolipin is an 
essential constituent of specific microdomains, localized at contact sites between the 
inner and outer mitochondrial membranes, from which it orchestrates apoptosis by 
integrating signals from a variety of death-inducing proteins to bring in close proximity 
caspase-8 and Bid to generate tBid where it is needed. In line with this emerging view, 
the oxidation of cardiolipin would imply the generation of its peroxidized form in sites 
close to MOM, facilitating the permeabilizing activity of oligomerized Bax. A critical 
aspect derived from the above considerations implies the redistribution of cardiolipin 
from the inner to the outer membrane to comply with the various steps of mitochondrial 
apoptosis it regulates (e.g. MOM permeabilization, cytochrome c mobilization). The 
underlying mechanism involved in the intramitochondrial trafficking of cardiolipin 
during apoptosis is not yet fully understood, although there is evidence indicating a 
multifactorial nature in this process. Mitochondrial creatine kinase has been shown to 
regulate the density of contact sites within mitochondrial membranes where cardiolipin 
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has been shown to reside [63]. In addition, Bid and mostly tBid exhibit lipid transfer 
activity contributing to the transbilayer movement of cardiolipin to the outer membrane 
[64, 65]. Moreover, phospholipid scramblases (PLS) induce non-specific bi-directional 
movement of phospholipids across the membrane. In particularly PLS3, a mitochondrial 
located PLS, has been shown to translocate cardiolipin from the MIM to the MOM 
during apoptosis induced by UV-irradiation [66, 67]. Nevertheless, regardless of the 
exact mechanism(s) involved, the translocation of cardiolipin between mitochondrial 
membranes has profound consequences in the mitochondrial apoptotic pathway, 
regulating the release of cytochrome c, mitochondrial bioenergetics and membrane 
perturbing effects such as the formation of cardiolipin-enriched microdomains, cristae 
remodelling and the accumulation of lyso-phospholipids. Further studies will be needed 
to establish if cholesterol, sphingolipids (e.g. GD3) and (peroxidized) cardiolipin are 
part of specific signaling domains which regulate the critcal steps of mitochondrial 
pathways of cell death. 
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6. CONCLUSIONS 
As an integral component, cholesterol plays an important role in the structure, physical 
properties and function of biological membranes. In particular, the mitohondrial 
cholesterol pool, which represents a minor proportion of the total cholesterol load, is 
emerging as an important factor in the regulation of mitochondrial membrane 
permeabilization and cell death. The enrichment of cholesterol in mitochondrial 
membranes determines the progression of liver and neurodegenerative diseases, and the 
resistance of cancer cells to current cancer therapy. Much of this effect of cholesterol is 
due to the changes in physical properties of mitochondrial membranes, especially in the 
appearance of lipid-ordered phases and subsequent loss of membrane fluidity that 
impairs mitochondrial function and specific membrane carriers. In particular, 
cholesterol loading in mitochondrial membranes selectively affects the transport of 
GSH into the matrix resulting in its depletion, which has a major impact on the 
stimulation of oxidant species derived from mitochondrial electron transport chain. As a 
consequence, cardiolipin becomes peroxidized, facilitating the redistribution of free 
cytochrome c to the intermembrane space and the permeabilization of mitochondrial 
outer membrane by Bax. Intriguingly, cholesterol plays a paradoxical role in cell death, 
being proapoptotic or antiapoptotic depending on whether mitochondrial GSH is 
depleted or not (Figure 2), which is in turn associated with the cardiolipin/peroxidized 
cardiolipin status. Thus, targeting mitochondrial cholesterol either by restraining its 
trafficking to or within mitochondrial membranes via StAR family members or by 
decreasing its availability (e.g. ezetimide or statins) may be of relevance for a number 
of pathologies such as steatohepatitis, neurodegenerative diseases or cancer. 
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FIGURE LEGENDS 
Figure 1. Cholesterol regulates the cardiolipin/peroxidized cardiolipin status. 
A, under physiological settings the pool of mitochonrial cholesterol is low allowing 
unimpaired transport of GSH into the mitochondrial matrix by the 2-oxoglutarate (2-OG) 
carrier, with a minor role for the dicarboxylate carrier (DIC), at least in rat liver 
mitochondria. In this scenario, the generation of ROS by cell death stimuli such as TNF, 
hypoxia or A , is controlled by GSH availability, ensuring the presence of intact 
cardiolipin in mitochondrial membranes. B, when the trafficking of cholesterol is 
stimulated as seen in different pathologies (e.g. ASH/NASH or Alzheimer´s disease), the 
mitochondrial transport of GSH via 2-OG is impaired resulting in GSH depletion which 
stimulates the generation of ROS in response to TNF causing cardiolipin peroxidation 
(CLOOH), which destabilizes the lipid bilayer and contributes to MOM permeabilization 
(MOMP) mediated by Bax. 
Figure 2. Paradoxical role of mitochondrial cholesterol in cell death. 
Since cholesterol regulates membrane dynamics and physical properties, the in situ 
enrichment in cholesterol impairs mitochondrial membrane permeabilization via MPT 
induced in response to atractyloside, which acts via adenine nucleotide translocator 
(ANT), Ca
2+
 or ROS, as well as the permeabilization of the outer membrane by active 
Bax. However, in pathological conditions associated with mitochondrial cholesterol 
trafficking and accumulation in both the inner and outer membranes via StAR expression 
potentiates mitochondrial membrane permeabilization in response to TNF/Fas, ROS, Bax 
or A  due to the mitochondrial GSH depletion. A role for the StAR family member 
MLN64 in the delivery of cholesterol to mitochondria remains to be fully established. 
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